J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 73 (1992), 1907-1913; DOI 10.1099/0022-1317-73-8-1907
© 1992 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morikawa, Y.
Right arrow Articles by Jones, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morikawa, Y.
Right arrow Articles by Jones, I. M.
Agricola
Right arrow Articles by Morikawa, Y.
Right arrow Articles by Jones, I. M.

Complementation of human immunodeficiency virus glycoprotein mutations in trans

Yuko Morikawa1,2, John P. Moore3,{dagger}, Emmanuel Fenouillet4 and Ian M. Jones1

1 NERC Institute of Virology, Mansfield Road, Oxford OX1 3SR, U.K.
2 The Kitasato Institute, 5-9-1 Shirogane, Minato-ku, Tokyo 108, Japan
3 Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, London SW3 6JB, U.K.
and4 CERVI, Hôpital Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75651 Paris cedex 13, France

The external glycoproteins of human immunodeficiency virus type 1 (HIV-1) (gp120) and HIV-2 (gp105) are responsible for binding the cellular receptor CD4. The proteins are functionally identical although their affinity for CD4 varies, with gp120 binding 10- to 20- fold more efficiently than gp105. To investigate the structural requirements for CD4 binding in each molecule we have constructed a number of hybrid glycoproteins in which sequences are exchanged between the two molecules via conserved residues and subsequently tested for their ability to bind to CD4. We found that two constructs in which the V1/V2 or V3 loops of gp105 are exchanged for those of gp120 continue to bind to CD4. Surprisingly, however, all other domain exchange mutants failed to bind to CD4 suggesting that long-range interactions within the molecule are sequence-specific. Mixing mutant molecules in vitro did not rescue CD4 binding. However, coexpression of a number of mutant glycoprotein pairs within the same cell produced complementation of CD4 binding ability; complementing molecules were shown to be heteromeric in structure. Alignment of the molecules within each complementation group allowed the interactive sequences necessary for receptor binding to be determined. These sequences constitute a novel target for the disruption of gp120 function.

{dagger} Present address: The Aaron Diamond AIDS Research Center, 455 First Avenue, 7th Floor, New York, New York 10016, U.S.A.

Received 9 January 1992; accepted 1 May 1992.


This article has been cited by other articles:


Home page
J. Virol.Home page
K. S. Cole, J. D. Steckbeck, J. L. Rowles, R. C. Desrosiers, and R. C. Montelaro
Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3
J. Virol., February 1, 2004; 78(3): 1525 - 1539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1992 by the Society for General Microbiology.